Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2457-1
Published Online: 2014-04-18
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salazar, Ramon
Morales, Serafin
Gil-MartÃn, Marta
Aguirre, Elena
Oaknin, Ana
Garcia, Margarita
Callies, Sophie
Wickremsinhe, Enaksha R.
Benhadji, Karim A.
Llombart, Antonio
Text and Data Mining valid from 2014-04-18